Invesaro

Stocks Comparison

LivaNova vs Outset Medical: revenue, profit, margins and growth compared

LivaNova brought in $1.4B of revenue in fiscal 2025, Outset Medical $119.5M in fiscal 2025. Revenue changed by +10.7% at LivaNova and +5.1% at Outset Medical on the year before, so LivaNova grew faster. LivaNova kept -17.5% of its revenue as net profit, Outset Medical -68.3%. Free cash flow was $173.3M at LivaNova and -$47.1M at Outset Medical.

Side by side, latest fiscal year

LIVNOM
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.4B$119.5M
Revenue growth+10.7%+5.1%
Net income-$242.5M-$81.7M
Net margin-17.5%-68.3%
Free cash flow$173.3M-$47.1M
Free cash flow margin12.5%-39.4%
Earnings per share (diluted)-$4.45-$5.37
Cash$635.6M$35M
Debt$376.1M$96.2M
Price to earningsn/an/a
Market value$4.2B$57.3M
Dividend yieldn/an/a
Rank by revenue in sector#130 of 523 · Health care#287 of 523 · Health care

Over the years

Revenue
LIVN FY2018: $1.1BLIVN FY2019: $1.1BLIVN FY2020: $934.2MLIVN FY2021: $1BLIVN FY2022: $1BLIVN FY2023: $1.2BLIVN FY2024: $1.3BLIVN FY2025: $1.4BOM FY2018: $2MOM FY2020: $15.1MOM FY2020: $49.9MOM FY2021: $102.6MOM FY2022: $115.4MOM FY2023: $130.4MOM FY2024: $113.7MOM FY2025: $119.5MFY18FY19FY20FY21FY22FY23FY24FY25
LIVN $1.4BOM $119.5M
Net income
LIVN FY2018: -$189.4MLIVN FY2019: -$157.6MLIVN FY2020: -$348.8MLIVN FY2021: -$135.8MLIVN FY2022: -$86.2MLIVN FY2023: $17.5MLIVN FY2024: $63.2MLIVN FY2025: -$242.5MOM FY2018: -$49.8MOM FY2020: -$68.3MOM FY2020: -$121.5MOM FY2021: -$131.9MOM FY2022: -$163MOM FY2023: -$172.8MOM FY2024: -$128MOM FY2025: -$81.7MFY18FY19FY20FY21FY22FY23FY24FY25
LIVN -$242.5MOM -$81.7M
Net margin
LIVN FY2018: -17.1%LIVN FY2019: -14.5%LIVN FY2020: -37.3%LIVN FY2021: -13.1%LIVN FY2022: -8.4%LIVN FY2023: 1.5%LIVN FY2024: 5.0%LIVN FY2025: -17.5%OM FY2018: -2,480.3%OM FY2020: -453.0%OM FY2020: -243.3%OM FY2021: -128.6%OM FY2022: -141.2%OM FY2023: -132.5%OM FY2024: -112.6%OM FY2025: -68.3%FY18FY19FY20FY21FY22FY23FY24FY25
LIVN -17.5%OM -68.3%
Revenue growth
LIVN FY2019: -2.1%LIVN FY2020: -13.8%LIVN FY2021: +10.8%LIVN FY2022: -1.3%LIVN FY2023: +12.9%LIVN FY2024: +8.7%LIVN FY2025: +10.7%OM FY2020: +651.3%OM FY2020: +231.2%OM FY2021: +105.5%OM FY2022: +12.4%OM FY2023: +13.0%OM FY2024: -12.8%OM FY2025: +5.1%FY19FY20FY21FY22FY23FY24FY25
LIVN +10.7%OM +5.1%
Free cash flow
LIVN FY2018: $83.3MLIVN FY2019: -$115.8MLIVN FY2020: -$114.4MLIVN FY2021: $77.1MLIVN FY2022: $43.4MLIVN FY2023: $39.9MLIVN FY2024: $135.9MLIVN FY2025: $173.3MOM FY2018: -$48.2MOM FY2020: -$73.6MOM FY2020: -$108.1MOM FY2021: -$133.4MOM FY2022: -$154.1MOM FY2023: -$134.8MOM FY2024: -$117.2MOM FY2025: -$47.1MFY18FY19FY20FY21FY22FY23FY24FY25
LIVN $173.3MOM -$47.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about LivaNova and Outset Medical

Which is bigger by revenue, LivaNova or Outset Medical?

LivaNova is bigger by revenue: $1.4B in fiscal 2025, against $119.5M for Outset Medical in fiscal 2025.

Which keeps more of its revenue as profit, LivaNova or Outset Medical?

LivaNova had a net margin of -17.5% in fiscal 2025; Outset Medical had -68.3% in fiscal 2025.

Which grew revenue faster, LivaNova or Outset Medical?

In their latest fiscal years revenue changed by +10.7% at LivaNova and +5.1% at Outset Medical.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies